United Therapeutics
UTHR
$231.78
Share price
-1.40%
Change (1 day)
0.62%
Change (1 year)
Categories
Number of shares outstanding for United Therapeutics (UTHR)
Number of shares outstanding as of April 2024 : 47,000,000
According to United Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 47,000,000. At the end of 2023 the company had 47,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for United Therapeutics from 2009 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 47 M | 2.62% |
| 2022 | 45.8 M | 1.55% |
| 2021 | 45.1 M | 1.35% |
| 2020 | 44.5 M | 1.37% |
| 2019 | 43.9 M | 0.69% |
| 2018 | 43.6 M | 0.93% |
| 2017 | 43.2 M | 2.37% |
| 2016 | 42.2 M | -7.63% |
| 2015 | 45.68 M | -3.68% |
| 2014 | 47.43 M | -5.67% |
| 2013 | 50.28 M | -2.39% |
| 2012 | 51.51 M | -11.67% |
| 2011 | 58.32 M | 3.16% |
| 2010 | 56.53 M | 5.76% |
| 2009 | 53.45 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 11,914.89% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | 1,919.96% | 🇺🇸 USA |
 Baxter BAX | 507,000,000 | 978.72% | 🇺🇸 USA |
 Gilead Sciences GILD | 1,248,000,000 | 2,555.32% | 🇺🇸 USA |
 Cardinal Health CAH | 245,000,000 | 421.28% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,028,000,000 | 4,214.89% | 🇬🇧 UK |
 Cytokinetics
CYTK | 99,067,000 | 110.78% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 2,285.11% | 🇮🇱 Israel |